Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
and 11,197,880 These statements have not been evaluated by the Food and Drug Administration
Patients should be educated to recognize symptoms that may indicate serious complications requiring clinical assessment or treatment modification
Efruxifermin did not significantly alter body weight over this 4-week trial but did significantly reduce the atherogenic lipoproteins ApoB and ApoC-III to a greater extent than did LY2405319 over the same period
It is expected to be administered weekly, starting with a lower dose to minimise side effects (1)
US$ 25.51
US$ 22.74
US$ 23.45
US$ 21.89
US$ 27.24
US$ 21.26
US$ 28.40
US$ 20.00
US$ 29.69
US$ 21.57
